Loading
Oxford Immunotec Global PLC Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BALTHROP PATRICK J, was filed 21 May 2020.
Oxford Immunotec Global PLC: what insiders have been doing
Oxford Immunotec Global PLC is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Oxford Immunotec Global PLC in twelve months, the latest record being from 12 March 2021.
The full history, which starts in 2016, counts 4 purchases against 53 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
148
Thresholds
n/a
Buy Volume
€506,901
4 ops. · all time
Sell Volume
€11M
53 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue65.6M
Gross profit48.5M74% margin
Net income-1.6M-2.5% margin
Last declaration on 12 March 2021
Declarations148 total
4,081 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008353:0
4,081 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008344:0
8,081 shares@ US$22.0076.6% of flowOrdinary SharesSEC:0001140361-21-008343:0
27,805 shares@ US$22.0099.8% of flowOrdinary SharesSEC:0001140361-21-008347:0
61,407 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008351:0
4,081 shares@ US$22.0010.0% of flowOrdinary SharesSEC:0001140361-21-008349:0
4,081 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008340:0
4,081 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008348:0
4,081 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008338:0
400,225 shares@ US$22.0044.4% of flowOrdinary SharesSEC:0001140361-21-008342:0
11,207 shares@ US$22.00100.0% of flowOrdinary SharesSEC:0001140361-21-008346:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013987:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013985:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013984:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013986:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013982:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013979:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013988:0
4,081 shares0Ordinary SharesSEC:0001437749-20-013980:0
4,000 shares@ US$12.48100.0% of flowOrdinary SharesSEC:0001437749-20-011569:0
Canonical exit: 18 Aug 2020 (T+90)
2,075 shares@ US$10.752.3% of flowOrdinary SharesSEC:0001437749-20-010441:0
Canonical exit: 6 Aug 2020 (T+90)
26,000 shares@ US$11.4530.4% of flowOrdinary SharesSEC:0001437749-20-010441:1
Canonical exit: 9 Aug 2020 (T+90)
15,525 shares@ US$11.5618.3% of flowOrdinary SharesSEC:0001437749-20-010441:2
Canonical exit: 10 Aug 2020 (T+90)
15,074 shares@ US$0.09100.0% of flowOrdinary SharesSEC:0001437749-20-005159:0
62,087 shares0Ordinary SharesSEC:0001437749-20-005157:0
25 of 148 declarations
About Oxford Immunotec Global PLC
Oxford Immunotec Global PLC is a company focused on developing diagnostic tests for infectious diseases, particularly tuberculosis. It is listed on NASDAQ under the ticker OXFD.
